Finland· FI-REL-REL6885

Adamix Vet

A a- ja d-vitamiinin yhdistelmävalmisteet product, registered in Finland by Pfizer Service Company BVBA.

ATC QA11CB

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedAdamix VetATCQA11CBREGISTER NO.FI-REL-REL6885PACKS LISTED0CHECKEDSeptember 27, 2026

The record

At a glance

Fimea (Finland)
Manufacturer
Pfizer Service Company BVBA
Country
Finland (FI)
ATC code
QA11CB
ATC class
A- ja D-vitamiinin yhdistelmävalmisteet
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under QA11CB

A- ja d-vitamiinin yhdistelmävalmisteet, as other registers publish it.

All Adamix products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dec04520-3dc5-4a88-85df-545cf04106c1
GET /v1/drugs/dec04520-3dc5-4a88-85df-545cf04106c1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "jauhe",
  "route": null,
  "ddd_unit": null,
  "strength": null,
  "atc_label": "A- ja D-vitamiinin yhdistelmävalmisteet",
  "ma_number": "1996",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL6885",
  "authorised_at": "1965-08-04"
}

See everything about Adamix.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.